/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

OLEMA PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights

OLEMA PHARMACEUTICALS INC share price today is $14.35, up -5.88%. The stock opened at $15.01 against the previous close of $14.96, with an intraday high of $15.01 and low of $14.05.

OLEMA PHARMACEUTICALS INC Share Price Chart

style
pb-0

OLEMA PHARMACEUTICALS INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

OLEMA PHARMACEUTICALS INC Share Price Performance

$14.35 -0.0588(-5.88%) OLMA at 23 Mar 2026 02:36 PM Biotechnology
Lowest Today 14.05
Highest Today 15.01
Today’s Open 15.01
Prev. Close 14.96
52 Week High 36.26
52 Week Low 2.86
Day’s Range: Low 14.05 High 15.01
52-Week Range: Low 2.86 High 36.26
1 day return -
1 Week return -14.96
1 month return -42.15
3 month return -50.02
6 month return +69.55
1 year return +224.65
3 year return +303.72
5 year return -62.95
10 year return -

OLEMA PHARMACEUTICALS INC Institutional Holdings

Bain Capital Life Sciences Investors, LLC 10.61

Paradigm Biocapital Advisors LP 9.41

Bvf Inc 6.61

FMR Inc 6.27

BlackRock Inc 5.90

HHG PLC 4.47

Vanguard Group Inc 4.44

Deep Track Capital, LP 4.33

Siren, L.L.C. 4.12

Logos Global Management LP 4.00

Franklin Resources Inc 3.76

RA Capital Management, LLC 3.24

Vanguard Total Stock Mkt Idx Inv 2.79

Lightspeed Management Co LLC 2.41

Vestal Point Capital LP 2.06

Polar Capital Healthcare Opports Inc 2.00

Morgan Stanley - Brokerage Accounts 1.94

Woodline Partners LP 1.85

iShares Russell 2000 ETF 1.81

Polar Capital Holdings PLC 1.72

Fidelity Select Health Care 1.60

Geode Capital Management, LLC 1.57

Defilade Capital Management, L.P. 1.54

Franklin Biotechnology Discv A(acc)USD 1.52

Citadel Advisors Llc 1.50

Belfius Equities Cure C Cap 1.29

Fidelity Advisor Biotechnology I 0.98

State Street® SPDR® S&P® Biotech ETF 0.93

Strategic Advisers Fidelity US TtlStk 0.91

Fidelity Advisor Health Care I 0.84

Janus Henderson Global Life Sciences 0.83

Janus Henderson Global Life Sciences D 0.83

Janus Henderson Glb Life Scn I2 USD 0.74

Fidelity Small Cap Index 0.73

Fidelity Select Biotechnology 0.72

Eventide Healthcare & Life Sciences I 0.71

Janus Global Life Science AUSD 0.71

Franklin Biotechnology Discovery A 0.69

Franklin US Small Cap Growth Equity 0.65

Janus Henderson Hrzn Biotec E2 USD 0.64

OLEMA PHARMACEUTICALS INC Market Status

Strong Buy: 5

Buy: 3

Hold: 0

Sell: 0

Strong Sell: 0

OLEMA PHARMACEUTICALS INC Fundamentals

Market Cap 1227.17 M

PB Ratio 2.5698

PE Ratio 0.0

Enterprise Value 728.54 M

Total Assets 533.43 M

Volume 8304999

OLEMA PHARMACEUTICALS INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-96062000 -96.1M, FY22:-102586000 -102.6M, FY21:-70886000 -70.9M, FY20:-22763000 -22.8M, FY19:-4316000 -4.3M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:-128000 -0.1M, Q3/2024:null 0.0M, Q2/2024:-94000 -0.1M

Quarterly Net worth Q3/2025:-42217000 -42.2M, Q2/2025:-43784000 -43.8M, Q1/2025:-30389000 -30.4M, Q3/2024:-34555000 -34.6M, Q2/2024:-30382000 -30.4M

About OLEMA PHARMACEUTICALS INC & investment objective

Company Information Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic ER-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivotal Phase 3 clinical trial of palazestrant as a monotherapy in second/third-line ER+/HER2- metastatic breast cancer; and palazestrant with CDK4/6 inhibitors, a phosphatidylinositol 3 kinase alpha (PI3Ka) inhibitor alpelisib, a mechanistic target of rapamycin inhibitor, and a CDK4 inhibitor that is in Phase 1b/2 clinical trial for the treatment of ER+/HER2- advanced or metastatic breast cancer. It also develops OP-3136, an orally-available small molecule that potently and selectively inhibits KAT6 which is in Phase 1 clinical trials for patients with breast and other solid tumor cancers. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Organisation Biotechnology

Employees 131

Industry Biotechnology

CEO Dr. Sean P. Bohen M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

OLEMA PHARMACEUTICALS INC FAQs

What is the share price of OLEMA PHARMACEUTICALS INC today?

The current share price of OLEMA PHARMACEUTICALS INC is $14.35.

Can I buy OLEMA PHARMACEUTICALS INC shares in India?

Yes, Indian investors can buy OLEMA PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy OLEMA PHARMACEUTICALS INC shares in India?

You can easily invest in OLEMA PHARMACEUTICALS INC shares from India by:

Can I buy fractional shares of OLEMA PHARMACEUTICALS INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of OLEMA PHARMACEUTICALS INC?

OLEMA PHARMACEUTICALS INC has a market cap of $1227.17 M.

In which sector does OLEMA PHARMACEUTICALS INC belong?

OLEMA PHARMACEUTICALS INC operates in the Biotechnology sector.

What documents are required to invest in OLEMA PHARMACEUTICALS INC stocks?

To invest, you typically need:

What is the PE and PB ratio of OLEMA PHARMACEUTICALS INC?

The PE ratio of OLEMA PHARMACEUTICALS INC is N/A and the PB ratio is 2.57.